PRFX
PRFX
NASDAQ · Pharmaceuticals

Prf Technologies Ltd

$0.87
+0.11 (+14.77%)
As of Nov 7, 2:47 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,273.3% upside
Low Target $8.59
Average Target $11.96
High Target $16.97
Current Price $0.87
Current
$0.87
Target
$11.96
$8.59 $11.96 avg $16.97
Scenario Analysis
Bear Case
$8.59
886.3%
Low target
Base Case
$11.96
+1,273.3%
Avg target
Bull Case
$16.97
+1,848.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.95
-89.0% from high
52-Week Low
$0.64
+35.9% from low
Target vs 52W High
$11.96
+50.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%